Japan

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories.... 2008-06-12

Another drugmaker has outlined an aggressive strategy to penetrate Japan's booming generic drug sector, confirming the trend that has emerged over the last six months. US-based Mylan... 2008-03-19

Due to a stagnating domestic market, two Japanese pharmaceutical wholesalers have revealed plans to establish joint ventures in China. Mediceo Paltac intends to provide drug management... 2008-02-22

Japanese firm Takeda is to develop and commercialise up to 13 molecules from US-based Amgen's pipeline for its domestic market. Amgen will receive US$200mn upfront, US$702mn in milestone... 2008-02-05

On the back of relatively strong economic growth in 2007, Japan has increased the amount it will spend on healthcare during 2008. BMI tends to welcomes such rises, but in this instance... 2008-01-16

Japanese drugmaker Astellas has announced that it is to cutback it operations in Germany becoming the latest sector player to disinvest in the country. Germany currently places... 2007-08-06

One of Japan's largest drugmakers, Eisai, is to make oncology a strategic priority in the mid-term ahead of US patent expiry of its best-selling product, the Alzheimer's disease therapeutic... 2007-07-19

In an effort to penetrate the under-developed Japanese generics market, Indian firm Zydus Cadila has bought local player Nippon Universal Pharmaceutical. While a prescient move in... 2007-04-19

A recent survey has claimed that the Japanese public's awareness of generic medicines is growing, although a reluctance to ask for these products still remains. According to a questionnaire... 2007-04-11

BMI has reinforced its favourable assessment of Japan's regulatory environment after the country's Pharmaceuticals and Medical Devices Agency (PMDA) delineated a biosimilar approval... 2007-03-30